Abstract
In 2015 Sheffield Teaching Hospitals NHS Foundation Trust became the first laboratory in the UK to install the Sebia CAPILLARYS 3 analyzer to perform HbA1c testing and Hemoglobinopathy screening. In this presentation Jason will talk about the decision-making process behind the adoption of this technology and in particular about his team’s experience in hemoglobinopathy diagnosis. Jason will also be presenting some case studies in order to show the practical application of Capillary Electrophoresis in the day to day setting of a busy screening laboratory.
Speaker’s biography
Jason began his career training as a Biomedical Scientist in the early 90’s at the Hammersmith Hospital, London, during which time he qualified as a Fellow of the Institute of Biomedical science. Following appointments at Senior Biomedical Scientist level at Southend University Hospital and Harlow Princess Alexandra Hospital, he now lives and works back in his native Sheffield. Jason is the Lead Biomedical Scientist for Hemoglobinopathies and Red Cell investigations at Sheffield Teaching Hospitals NHS Foundation Trust, and the ‘Expert Assessor’ for the NEQAS Abnormal Hb EQA scheme.
Relatore
CAPILLARYS 3 TERA MC
La potenza di 36 capillari in una workcell automatica per alti volumi.
Screening dei disordini dell’emoglobina
Il metodo ad alta risoluzione per lo screening dei disordini dell’emoglobina.
Questa sezione contiene informazioni destinate a un’ampia distribuzione e potrebbe pertanto contenere dettagli dei prodotti o informazioni non disponibili o valide nel vostro paese.
Contattare il rappresentante Sebia locale. Informazioni destinate agli operatori sanitari.
Leggere attentamente le istruzioni contenute nei foglietti illustrativi dei reagenti e nei manuali degli strumenti.